YS Biopharma Co Analyst Ratings
YS Biopharma Co Analyst Ratings
While ratings are subjective and will change, the latest YS Biopharma Co (YS) rating was a initiated with a price target of $0.00 to $5.25. The current price YS Biopharma Co (YS) is trading at is $0.59, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 795.9% | Noble Capital Markets | → $5.25 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/13/2023 | 795.9% | 貴族資本市場 | → 5.25 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for YS Biopharma Co (YS)?
YS Biopharma Co（YS）的目標價格是多少？
The latest price target for YS Biopharma Co (NASDAQ: YS) was reported by Noble Capital Markets on November 13, 2023. The analyst firm set a price target for $5.25 expecting YS to rise to within 12 months (a possible 795.90% upside). 1 analyst firms have reported ratings in the last year.
諾布爾資本市場於2023年11月13日公佈了YS Biopharma Co（納斯達克股票代碼：YS）的最新目標股價。該分析公司將目標股價定爲5.25美元，預計YS將在12個月內升至12個月內（可能上漲795.90％）。1家分析公司去年公佈了評級。
What is the most recent analyst rating for YS Biopharma Co (YS)?
YS Biopharma Co（YS）的最新分析師評級是多少？
The latest analyst rating for YS Biopharma Co (NASDAQ: YS) was provided by Noble Capital Markets, and YS Biopharma Co initiated their outperform rating.
諾布爾資本市場對YS Biopharma Co（納斯達克股票代碼：YS）的最新分析師評級由諾布爾資本市場提供，YS Biopharma Co啓動了跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for YS Biopharma Co (YS)?
YS Biopharma Co（YS）的下一次分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of YS Biopharma Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for YS Biopharma Co was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與YS Biopharma Co的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。YS Biopharma Co的最新評級是在2023年11月13日公佈的，因此您應該預計下一個評級將在2024年11月13日左右公佈。
Is the Analyst Rating YS Biopharma Co (YS) correct?
分析師對YS Biopharma Co（YS）的評級是否正確？
While ratings are subjective and will change, the latest YS Biopharma Co (YS) rating was a initiated with a price target of $0.00 to $5.25. The current price YS Biopharma Co (YS) is trading at is $0.59, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但YS Biopharma Co（YS）的最新評級是啓動的，目標股價爲0.00美元至5.25美元。YS Biopharma Co（YS）目前的交易價格爲0.59美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
